Accelerated radiotherapy with delayed concomitant boost in locally advanced squamous cell carcinoma of the head and neck (Q73090104)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10524410%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Accelerated radiotherapy with delayed concomitant boost in locally advanced squamous cell carcinoma of the head and neck (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10524410%20AND%20SRC:MED&resulttype=core&format=json

head and neck squamous cell carcinoma

1 November 2019

main subject

1 reference

R MacKenzie

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10524410%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

J Balogh

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10524410%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

R Choo

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10524410%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

E Franssen

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10524410%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

language of work or name

English

0 references

publication date

1 October 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10524410%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Radiation Oncology Biology Physics

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10524410%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10524410%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

589-595

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10524410%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10524410%20AND%20SRC:MED&resulttype=core&format=json

Carcinoma of the tonsil: the effect of dose-time-volume factors on local control

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900218-7

7 January 2021

Carcinoma of the tonsillar fossa: a nonrandomized comparison of preoperative radiation and surgery or irradiation alone: long-term results

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900218-7

7 January 2021

Carcinoma of the oropharynx. Results of megavoltage radiation therapy in 305 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900218-7

7 January 2021

Split-course radiation therapy of carcinoma of the base of the tongue: Results of a prospective national collaborative clinical trial conducted by the radiation therapy oncology group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900218-7

7 January 2021

Carcinoma of the hypopharynx results of primary radical radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900218-7

7 January 2021

The steepness of the dose response curve both for tumor cure and normal tissue injury

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900218-7

7 January 2021

Local control and site of failure in radically irradiated supraglottic laryngeal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900218-7

7 January 2021

Management of advanced glottic cancer a 10 year review of the Toronto experience

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900218-7

7 January 2021

Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900218-7

7 January 2021

Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900218-7

7 January 2021

Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stages III and IV oropharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900218-7

7 January 2021

The hazard of accelerated tumor clonogen repopulation during radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900218-7

7 January 2021

Loss of local control with prolongation in radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900218-7

7 January 2021

Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900218-7

7 January 2021

Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900218-7

7 January 2021

A randomised trial of accelerated versus conventional radiotherapy in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900218-7

7 January 2021

Randomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer. Preliminary report on acute toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900218-7

7 January 2021

A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900218-7

7 January 2021

Accelerated versus conventional fractionation in the postoperative irradiation of locally advanced head and neck cancer: influence of tumour proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900218-7

7 January 2021

Concomitant boost radiotherapy for advanced squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900218-7

7 January 2021

Concomitant chemotherapy-radiation therapy followed by hyperfractionated radiation therapy for advanced unresectable head and neck cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900218-7

7 January 2021

Accelerated fractionation radiotherapy for laryngeal cancer, acute, and late toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900218-7

7 January 2021

Postoperative accelerated radiotherapy in high-risk squamous cell carcinoma of the head and neck: long-term results of a prospective trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900218-7

7 January 2021

Accelerated radiotherapy with carbogen and nicotinamide (ARCON) for laryngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900218-7

7 January 2021

ASTRO plenary: interfraction interval is a major determinant of late effects, with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts: results from Radiation Therapy Oncology Group protocol 8313

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900218-7

7 January 2021

An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900218-7

7 January 2021

Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900218-7

7 January 2021

Why has induction chemotherapy for advanced head and neck cancer become a United States community standard of practice?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900218-7

7 January 2021

10.1016/S0360-3016(99)00218-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10524410%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference